94 results on '"Nozza, A"'
Search Results
2. Rectal Lymphogranuloma Venereum Among Men Who Have Sex With Men: 7 Versus 21 Days Doxycycline Effectiveness
3. Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation
4. Meningococcus B Vaccination Effectiveness against Neisseria gonorrhoeae Infection in People Living with HIV: a Case-control Study
5. HIV viral load monitoring during monkeypox virus infection among people with HIV
6. HIV viral load monitoring during monkeypox virus infection among people with HIV
7. Pattern of Atrial Fibrillation and Cognitive Function in Young Patients With Atrial Fibrillation and Low CHADS2 Score: Insights From the BRAIN-AF Trial
8. Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY
9. Viro-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression
10. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study
11. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology
12. Diagnostic Criteria of Pediatric Intestinal Myopathies
13. Congenital Myoepithelial Carcinoma of Soft Tissue Associated With Cystic Myoepithelioma
14. Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes
15. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open‐label trial
16. Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients
17. Epilepsy surgery of “low grade epilepsy associated neuroepithelial tumors”: A retrospective nationwide Italian study
18. Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study
19. TRAP1 controls cell cycle G2–M transition through the regulation of CDK1 and MAD2 expression/ubiquitination
20. Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection
21. SMARCB1/INI1 Involvement in Pediatric Chordoma: A Mutational and Immunohistochemical Analysis
22. Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection
23. Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment
24. Respiratory Distress in a 3-Month-Old Infant with a Mass Obstructing the Right Main-Stem Bronchus: An Unusual Localization of Infantile Hemangioma
25. Distinctive Genetic Profile With IDH1, TP53, and MLH1 Mutations in a Radiation-Induced Anaplastic Astrocytoma
26. Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients
27. Immortal time bias: authors’ reply
28. Is statin preventing cancer in HIV-1 infected individuals? An inappropriate methodology is a more likely explanation: authors’ reply
29. Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019
30. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy
31. Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results
32. Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients
33. Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients
34. Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection
35. Pituitary deficiency and congenital infiltrating lipomatosis of the face in a girl with deletion of chromosome 1q24.3q31.1
36. Highlights on HIV eradication in 2013
37. Pharmacokinetics of maraviroc administered at 150 mg once daily in association with lopinavir/ritonavir in HIV-positive treatment-naive patients
38. B-cell subset alterations and correlated factors in HIV-1 infection
39. Immune recovery and T cell subset analysis during effective treatment with maraviroc
40. Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
41. A 3-YEAR-OLD BOY WITH DRUG-RESISTANT COMPLEX PARTIAL SEIZURES
42. Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double-Strand Break-Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein
43. Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts
44. Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma
45. Troubleshooting fine-tuning procedures for qPCR system design
46. Pharmacokinetics of the raltegravir/maraviroc/etravirine combination
47. Megacystis, megacolon, and malrotation: A new syndromic association?
48. Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption
49. Prognostic factors and outcome of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with multiple myeloma relapsed after autografting and rescued with new drugs: P882
50. Outcome of Hodgkinʼs lymphoma and aggressive non-Hodgkin lymphoma patients refractory to salvage chemotherapy: P862
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.